---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-23-000032"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2023-05-25T23:59:59+00:00"
generated_at: "2026-06-14T14:35:45.881418+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medtronic Q4 revenue beats at $8.5B (+5.6%); raises dividend to $0.69 quarterly

## Summary
- Q4 GAAP EPS $0.88 (-20% YoY); non-GAAP EPS $1.57 (+3%), ahead of expectations.
- FY23 revenue $31.2B (-1.4% reported, +2.1% organic); FY organic growth guided 4.0-4.5%.
- Dividend increased to $0.69/share quarterly ($2.76 annual); 46th consecutive annual increase.
- Announced definitive agreement to acquire EOFlow Co. Ltd. (EOPatch tubeless insulin pump).
- FY24 non-GAAP EPS guidance $5.00-$5.10; revenue positively impacted by FX ~$110-210M.

## SEC filing metadata
- accession: 0001613103-23-000032
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2023-05-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000032/0001613103-23-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000032/mdt-20230525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-23-000032
- JSON: https://secwatch.observer/filing/0001613103-23-000032.json
- Plain text: https://secwatch.observer/filing/0001613103-23-000032.txt

## Key facts
- Earnings Releases
  Medtronic plc reported fiscal year 2023 results: revenue $31.227 billion, net income $3.758 billion, EPS $2.82.
  - Period: fiscal year 2023
  - Revenue: $31.227 billion
  - Net income: $3.758 billion
  - EPS: $2.82
  - Result: reported results
  source text: non-GAAP diluted EPS were $2.093 billion and $1.57, respectively, both increases of 3%. Fiscal Year 2023 (FY23) Financial Results Medtronic reported FY23 worldwide revenue of $31.227 billion, a decrease of 1.4% as reported and an increase of 2.1% on an organic basis. The FY23 organic revenue growth comparison excludes: • a $1.437 billion negative impact from foreign
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000032/0001613103-23-000032-index.htm
- Earnings Releases
  Medtronic plc reported fourth quarter fiscal year 2023 results: revenue $8.5 billion, net income $1.179 billion, EPS $0.88.
  - Period: fourth quarter fiscal year 2023
  - Revenue: $8.5 billion
  - Net income: $1.179 billion
  - EPS: $0.88
  - Result: reported results
  source text: Q4 revenue of $8.5 billion increased 5.6% as reported and organic, ahead of expectations • Q4 GAAP diluted EPS of $0.88 decreased 20%; non-GAAP diluted EPS of $1.57 increased 3% in the quarter, ahead of expectations
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000032/0001613103-23-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.